A recent report implicating VIM-AS1 in TGF-β-induced tissue fibrosis [65], suggests that our findings may have broader significance in human diseases beyond cancer, where TGF-β signaling plays key roles, such as fibrotic and chronic inflammatory conditions. This evidence concerns the gene VIM-AS1 and cancer.